Japan

Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Tue, 11/20/18 - 12:17 pm
Takeda
shareholders
Japan
M&A
Shire
Europe
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
CNBC
Tue, 10/23/18 - 10:57 pm
JNJ
M&A
Japan
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Fri, 09/28/18 - 10:34 am
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Exelixis
Cabometyx
Takeda
Canada
Japan
Ipsen
renal cell carcinoma
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
Tue, 08/21/18 - 10:08 am
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Yahoo/Zacks.com
Mon, 08/13/18 - 05:52 pm
Shire
Shionogi
ADHD
Japan
Intuniv
Pharma reps get more respect from doctors in Japan. What's the takeaway for U.S. reps?
Fierce Pharma
Mon, 08/6/18 - 11:55 pm
drug reps
Japan
Pharma reps and websites carry clout with physicians in Japan
Decision Resources Group
Tue, 07/31/18 - 07:02 pm
Japan
pharma reps
Decision Resources Group
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
CP Wire
Fri, 07/13/18 - 11:55 am
AB928
Arcus Biosciences
Taiho Pharmaceutical
oncology
Asia
Japan
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Thu, 07/5/18 - 10:50 am
Takeda
Shire
M&A
Japan
AstraZeneca wins speedy approvals for cancer drugs in Japan
Yahoo/Reuters
Mon, 07/2/18 - 09:23 am
AstraZeneca
Japan
Imfinzi
Lynparza
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
Sat, 06/9/18 - 10:11 am
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Thu, 05/10/18 - 09:32 am
Astellas
Aquinox Pharmaceuticals
SHIP1 activator
Japan
Asia
rosiptor
Myriad’s breast cancer diagnostic wins approval in Japan
Drug Delivery Business News
Mon, 04/2/18 - 09:27 am
Myriad Genetics
diagnostics
breast cancer
Japan
Bracanalysis Diagnostic System
Lynparza
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Drug Delivery Business News
Fri, 03/23/18 - 09:45 am
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
Reimbursement Trends for Medical Devices in Japan
Medical Devices and Diagnostics Industry
Tue, 03/6/18 - 09:28 am
devices
Japan
reimbursement
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Fierce Pharma
Wed, 02/28/18 - 11:14 am
Japan
Shionogi
Flu
influenza
Xofluza
Shionogi, Roche get their first approval for the next big thing in fighting the flu
Endpoints
Fri, 02/23/18 - 09:28 am
Shionogi
Roche
Flu
influenza
Xofluza
Japan
Tamiflu
Why Thailand is an Untapped Medtech Opportunity
Medical Devices and Diagnostics Industry
Mon, 02/12/18 - 09:08 am
devices
Thailand
Japan
medical tourism
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
Sat, 01/20/18 - 02:56 pm
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat

Pages